Carrollton BancorpThis Baltimore bank holding company said...

BY THE NUMBERS

August 14, 1992

Carrollton Bancorp

This Baltimore bank holding company said better net interest margins, higher fee income and stronger loan demand helped it boost earnings 27 percent during the first half of the year.

The parent company of Carrollton Bank reports earnings twice a year.

Six Months ended 6/30/92

... ... Income... ... ... ... Share

'92 ... 903,000 ... .... ... 1.23

'91 ... 709,000 ... .... ... 0.96

% change +27.4... ... ... ... +28.1

... ... Assets... ... ... ... Deposits

'92 ... 200,561,000... ... . 173,875,000

'91 ... 198,241,000... ... . 172,803,000

% change +1.2... ... .. ... . +0.6

BTR Realty

This Linthicum-based real estate developer saw its operating earnings before depreciation and deferred taxes jump and its net loss shrink during the second quarter as it struggled to

overcome the recession.

BTR said operating earnings were $339,000 higher than in last year's second quarter and that cash flow was helped by the sale of its development rights to a shopping center in North Carolina.

Three months ended 6/30/92

......Revenue... .... .... Net.... .... .... Share

'92.. 6,322,668 ... ..... (403,228) ... ...(0.04)

'91.. 6,695,219 ... ..... (429,281) ... ...(0.05)

% change 5.6... ... ... ... --... ... ... ... --

Six months ended 6/30/92

......Revenue... .... .... Net.... .... .... Share

'92... 11,933,536... .... (631,652)... ... (0.07)

'91... 11,484,069... .... (1,273,132). ... (0.15)

% change +3.9... ... .. ... -- ... ... ... ...--

Kirschner Medical Corp.

This Timonium-based company, which sells orthopedic and surgical supplies, reported income of $179,000 or .07 cents a share for the quarter ended June 30.

The drop in earnings for the second quarter was attributed to higher operating expenses, including increased international marketing expenses and higher professional fees related to the company's efforts to get capital.

Three months ended 6/30/92

......Revenue... .... .... Net.... .... .... Share

'92 ...18,259,000... .. 179,000... ... ... 0.07

'91 ...18,333,000... .. 953,000... ... ... 0.38

% change -0.4... ... ... -81.2... ... ... ...-81.6

Six months ended 6/30/91

......Revenue... .... .... Net.... .... .... Share

'92...36,854,000... ... . 1,184,000... ... 0.46

'91...36,428,000... ... . 1,623,000... ... 0.65

% change +1.2... ... ... .. -27... ... ... .. -29.2

Igene Biotechnology

This Columbia-based biotechnology company reported another quarterly loss in the period that ended June 30.

The company, which has developed a food for pond-raised salmon, sold common stock recently to raise cash needed for producing and marketing its new product, called AstaXin.

Three months ended 6/30/92

......Revenue... .... .... Net.... .... .... Share

'92...59,928... ... .... (250,784)... .... (0.02)

'91...26,110... ... .... (258,530)... .... (0.02)

% change +129.5... ... ... -- ... ... ... ...--

Six months ended 6/30/92

......Revenue... .... .... Net.... .... .... Share

'92.. 136,961.. .... .... (412,290).. .... (0.04)

'91.. 105,839.. .... .... (479,584).. .... (0.05)

% change +29.4... ... ... ... --... ... ... .. --

Baltimore Sun Articles
|
|
|
Please note the green-lined linked article text has been applied commercially without any involvement from our newsroom editors, reporters or any other editorial staff.